G267-0982 Screening compound: ethyl 3-(3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}propanamido)benzoate

G267-0982 Screening compound: ethyl 3-(3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}propanamido)benzoate
G267-0982 Screening compound: ethyl 3-(3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}propanamido)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound G267-0982
ethyl 3-(3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}propanamido)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G267-0982

Molecular Formula

C25H30N6O4 (C25 H30 N6 O4)

Compound Name

ethyl 3-(3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}propanamido)benzoate

IUPAC name

ethyl 3-(3-{35-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}propanamido)benzoate

SMILES

CCOC(c1cc(NC(CCc2c(C)n(-c(cc3)nnc3N3CCOCC3)nc2C)=O)ccc1)=O

InChI

InChI=1S/C25H30N6O4/c1-4-35-25(33)19-6-5-7-20(16-19)26-24(32)11-8-21-17(2)29-31(18(21)3)23-10-9-22(27-28-23)30-12-14-34-15-13-30/h5-7,9-10,16H,4,8,11-15H2,1-3H3,(H,26,32)

InChI Key

ZCJWQPZFAWJXIL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14992380

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

478.55

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.251

Distribution Coefficient, logD

3.180

Water Solubility, LogSw

-3.39

Polar Surface Area

90.319

Acid Dissociation Constant (pKa)

11.81

Base Dissociation Constant (pKb)

6.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

G267-0982 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Akt-Targeted Library (14764 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G267-0982 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G267-0982?
Check Price and Availability of G267-0982, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G267-0982 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G267-0982
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G267-0982
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G267-0982 available by request